Although there are no head-to-head trials, available data cited above suggest that cabergoline may be more effective than bromocriptine in patients with Cushing's disease with a 30–40% response ...

Management. The patient was treated with whole-gland pituitary extract, which improved his symptoms only temporarily. Cushing transplanted a pituitary gland obtained from a spontaneously aborted ...

Below you will find portraits of some of Dr. Cushing’s patients from back in the 20th century, so scroll down to view them, ...

Salivary cortisol measurements are particularly useful to investigate cyclical Cushing's syndrome ... A useful out-patient first-line investigation Loss of diurnal rhythm of cortisol production ...

Relacorilant improved blood pressure and other parameters at 24 months for patients with Cushing’s syndrome. No new safety issues related to the drug emerged. Among patients with endogenous ...

Corcept Therapeutics Incorporated CORT recently announced the submission of a new drug application (NDA) to the FDA for its ...

Giselle Cushing, southeast region president at Aetna®, discusses how enhanced primary care solutions can help companies in ...

Korlym showed a 1.47% reduction in hemoglobin A1c in patients with hypercortisolism and type 2 diabetes, surpassing placebo's 0.15%. CATALYST Phase 4 study screened 1,057 patients, confirming ...

The alliance between the Cushing’s Support and Research Foundation (CSRF) and digital health company Ubie will validate and fine-tune symptom checker software that they hope will help patients ...

About Hypercortisolism (Cushing’s Syndrome) Hypercortisolism is caused by excessive activity of the hormone cortisol. Symptoms vary, but most patients experience one or more of the following ...